{"id":"https://openalex.org/W4390698704","doi":"https://doi.org/10.3389/fonc.2023.1335987","title":"Perspective: rethinking therapeutic strategies in oncology","display_name":"Perspective: rethinking therapeutic strategies in oncology","publication_year":2024,"publication_date":"2024-01-10","ids":{"openalex":"https://openalex.org/W4390698704","doi":"https://doi.org/10.3389/fonc.2023.1335987","pmid":"https://pubmed.ncbi.nlm.nih.gov/38269024","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10805859"},"language":"en","primary_location":{"id":"doi:10.3389/fonc.2023.1335987","doi":"https://doi.org/10.3389/fonc.2023.1335987","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2023.1335987","pdf_url":"https://www.frontiersin.org/articles/10.3389/fonc.2023.1335987/pdf?isPublishedV2=False","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fonc.2023.1335987/pdf?isPublishedV2=False","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024146445","display_name":"Edward F. Patz","orcid":"https://orcid.org/0000-0003-3374-1596","observed_orcids":["https://orcid.org/0000-0003-3374-1596"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Edward F. Patz","raw_affiliation_strings":["Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC, United States","Department of Radiology, Duke University School of Medicine, Durham, NC, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC, United States","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]},{"raw_affiliation_string":"Department of Radiology, Duke University School of Medicine, Durham, NC, United States","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002085317","display_name":"Elizabeth B. Gottlin","orcid":"https://orcid.org/0000-0003-0886-0024","observed_orcids":["https://orcid.org/0000-0003-0886-0024"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth B. Gottlin","raw_affiliation_strings":["Department of Radiology, Duke University School of Medicine, Durham, NC, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiology, Duke University School of Medicine, Durham, NC, United States","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5102964486","display_name":"George R. Simon","orcid":"https://orcid.org/0000-0002-3894-0773","observed_orcids":["https://orcid.org/0000-0002-3894-0773"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"George R. Simon","raw_affiliation_strings":["Department of Medical Oncology at Advent Health, Moffitt Cancer Center, Tampa, FL, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology at Advent Health, Moffitt Cancer Center, Tampa, FL, United States","institution_ids":["https://openalex.org/I3019308854"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5024146445"],"corresponding_institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"],"apc_list":{"value":3295,"currency":"USD","value_usd":3295},"apc_paid":{"value":3295,"currency":"USD","value_usd":3295},"fwci":0.3407,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.55855626,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":90,"max":96},"biblio":{"volume":"13","issue":null,"first_page":"1335987","last_page":"1335987"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.9160000085830688},{"id":"https://openalex.org/keywords/tumor-immunology","display_name":"tumor immunology","score":0.9649999737739563},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.8700000047683716},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.48100000619888306},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.6000000238418579},{"id":"https://openalex.org/keywords/immunotherapy-development","display_name":"immunotherapy development","score":0.6439999938011169},{"id":"https://openalex.org/keywords/clinical-trial-design","display_name":"clinical trial design","score":0.6570000052452087},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.5}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6929308176040649},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5441521406173706},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5111961960792542},{"id":"https://openalex.org/C12713177","wikidata":"https://www.wikidata.org/wiki/Q1900281","display_name":"Perspective (graphical)","level":2,"score":0.5063241720199585},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5022552013397217},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.48754093050956726},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.4838915765285492},{"id":"https://openalex.org/C2983331546","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer therapy","level":3,"score":0.47097185254096985},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3695170283317566},{"id":"https://openalex.org/C19527891","wikidata":"https://www.wikidata.org/wiki/Q1120908","display_name":"Medical physics","level":1,"score":0.32178187370300293},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.31336191296577454},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.31222212314605713},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2662913203239441},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.18035775423049927},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.14035660028457642},{"id":"https://openalex.org/C154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","level":1,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fonc.2023.1335987","doi":"https://doi.org/10.3389/fonc.2023.1335987","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2023.1335987","pdf_url":"https://www.frontiersin.org/articles/10.3389/fonc.2023.1335987/pdf?isPublishedV2=False","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10805859","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10805859","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10805859/pdf/fonc-13-1335987.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Oncol","raw_type":"Text"},{"id":"pmid:38269024","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38269024","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in oncology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:f9485eae69664fc9a1e960c31b31dc8d","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/f9485eae69664fc9a1e960c31b31dc8d","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Oncology, Vol 13 (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fonc.2023.1335987","doi":"https://doi.org/10.3389/fonc.2023.1335987","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2023.1335987","pdf_url":"https://www.frontiersin.org/articles/10.3389/fonc.2023.1335987/pdf?isPublishedV2=False","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9074000120162964}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4390698704.pdf","grobid_xml":"https://content.openalex.org/works/W4390698704.grobid-xml"},"referenced_works_count":19,"referenced_works":["https://openalex.org/W1999712359","https://openalex.org/W2068854404","https://openalex.org/W2586629973","https://openalex.org/W2981803901","https://openalex.org/W3107262098","https://openalex.org/W3110077847","https://openalex.org/W3110987629","https://openalex.org/W3151427897","https://openalex.org/W3207622291","https://openalex.org/W4221016133","https://openalex.org/W4223502512","https://openalex.org/W4290614528","https://openalex.org/W4294940369","https://openalex.org/W4297093085","https://openalex.org/W4297102201","https://openalex.org/W4366823282","https://openalex.org/W4379209546","https://openalex.org/W4385852104","https://openalex.org/W4386475855"],"related_works":["https://openalex.org/W2107752843","https://openalex.org/W4292260448","https://openalex.org/W4404802973","https://openalex.org/W2766617647","https://openalex.org/W4413234409","https://openalex.org/W3206942113","https://openalex.org/W7097456980","https://openalex.org/W4282034865","https://openalex.org/W4411739958","https://openalex.org/W2093188850"],"abstract_inverted_index":{"Immuno-oncology":[0],"has":[1],"revolutionized":[2],"cancer":[3],"care,":[4],"drug":[5],"development,":[6],"the":[7,16,41,46,51,61,64,80,90],"design":[8],"of":[9,18,33,56,63,82],"clinical":[10],"trials,":[11],"standard":[12],"treatment":[13],"paradigms,":[14],"and":[15,49],"evaluation":[17],"response":[19],"to":[20,88],"therapy.":[21],"These":[22],"are":[23],"all":[24],"areas,":[25],"however,":[26],"that":[27,53],"have":[28,44,59],"not":[29],"fully":[30],"incorporated":[31],"principles":[32],"tumor":[34],"immunology.":[35],"Insufficient":[36],"emphasis":[37],"is":[38,86],"put":[39],"on":[40,45,60],"effect":[42],"drugs":[43],"immune":[47,65,71],"system,":[48,66],"specifically,":[50],"impact":[52],"multiple":[54],"lines":[55],"therapy":[57],"can":[58],"functioning":[62],"hindering":[67],"a":[68],"robust":[69],"anti-tumor":[70],"response.":[72],"A":[73],"paradigm":[74],"shift":[75],"in":[76,93],"how":[77],"we":[78],"approach":[79],"development":[81],"novel":[83],"immunotherapeutic":[84],"agents":[85],"necessary":[87],"facilitate":[89],"effective":[91],"improvements":[92],"patient":[94],"outcomes.":[95]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1}],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2024-01-13T00:00:00"}